Related Experiment Video

Updated: Feb 10, 2026

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

2.0K

Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis

Leonie Beljaars1, Dirk K F Meijer, Klaas Poelstra

  • 1Groningen University Institute for Drug Exploration, Dept. of Pharmacokinetics and Drug Delivery, University Center for Pharmacy, Groningen, The Netherlands. L.Beljaars@farm.rug.nl

Frontiers in Bioscience : a Journal and Virtual Library
|May 7, 2002
PubMed

Insights

Targeting hepatic stellate cells (HSC) with drugs offers a promising strategy to treat liver fibrosis. Albumin-based carriers enable selective drug delivery to HSC, improving therapeutic efficacy and reducing side effects.

Area of Science:

  • Hepatology
  • Pharmacology
  • Cell Biology

Background:

  • Hepatic stellate cells (HSC) are central to liver fibrosis development.
  • Current anti-fibrotic drugs targeting HSC show limited in vivo efficacy due to poor uptake or off-target side effects.
  • Selective drug delivery to HSC is a potential therapeutic advancement.

Purpose of the Study:

  • To review drugs targeted to HSC for liver fibrosis treatment.
  • To discuss challenges and strategies in HSC-targeted therapy.
  • To explore the potential of selective gene and drug delivery to HSC.

Main Methods:

  • Review of existing literature on HSC-targeted therapies.
  • Discussion of albumin-based carriers for HSC drug delivery.
  • Analysis of challenges in selective delivery strategies.

Main Results:

  • Albumin-based carriers demonstrate preferential distribution to HSC in fibrotic rat livers.
  • Selective delivery of drugs and genes to HSC is a feasible strategy.
  • Challenges in achieving effective in vivo drug uptake and minimizing side effects were identified.

Conclusions:

  • Targeted delivery of anti-fibrotic agents to HSC represents a promising therapeutic approach.
  • Further research is needed to overcome challenges in HSC-targeted drug and gene delivery.
  • Optimizing drug carriers and delivery systems can enhance liver fibrosis treatment outcomes.

More Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K
Seven Steps to Stellate Cells06:40

Seven Steps to Stellate Cells

Published on: May 10, 2011

34.8K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
207
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.6K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

No description available
5.6K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
891